FREE Account Opening + No Clearing Fees
Loading...
August 29, 2022 - September 5, 2022

EP Biocomposites IPO Review & Recommendations

Dilip Davda recommend to "Avoid" the IPO.

EP Biocomposites IPO Review Summary from brokers and analysts

Review By Apply May Apply Neutral Avoid Not Rated
Count 0 0 0 1 0
% 0.00 0.00 0.00 100.00 0.00

EP Biocomposites IPO Analysis By Brokers/Analysts

Reviewer Recommendation Past Reviews
Dilip Davda Avoid

EP Biocomposites IPO Review by Dilip Davda (Avoid)

[Dilip Davda]  Though the company has posted steady growth in its top and bottom lines, its tiny post-IPO paid-up equity capital indicates longer gestation for migration to the mainboard. Based on FY22 earnings, its IPO is priced aggressively. This pricy issue may be skipped. Read detail review...


EP Biocomposites IPO Review by Members

EP Biocomposites IPO Reviews, analysis and views by popular members. Read EP Biocomposites Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

EP Biocomposites IPO Review Summary by Members

Review By Apply May Apply Neutral Avoid
Count 0 0 2 1
% 0.00 0.00 66.67 33.33
Clear Search
Member Review
Ipoyes

Neutral

Ok sme

September 2, 2022 11:36:11 AM
GOEL STOCK LINK

Neutral

FULLY PRICED, RISKY IPO. YOU CAN APPLY FOR LISTING GAIN .

September 1, 2022 4:28:17 PM
Bull Morris

Avoid

I do not think, to get listing gain in this company. The company is very old but it has launched IPO now, may be due to some internal issues. I want expert opinion whether to apply or not ...?

August 26, 2022 3:36:41 PM

Post Recommendation Manage Recommendations

Note:

  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.